View all publications by Redenlab

Redenlab is dedicated to advancing research in the field of speech, language, and cognitive disorders, particularly in the context of neurodegenerative diseases. With a focus on providing innovative solutions and insights, Redenlab partners with leading academic and research institutions to improve diagnosis, care, and treatment outcomes for individuals affected by these conditions.

To explore all of Redenlab’s published work, visit our collection of publications here.

Related Post

Redenlab awarded $2.5M to scale AI-driven speech biomarkers for dementia detection 

  • Posted on 29 September, 2025
    MEDIA RELEASE MELBOURNE, VIC – We’re pleased to share that Redenlab has been awarded $2.5 million in non-dilutive funding through...
    Read more

    Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia

    • Posted on 25 July, 2025
      A new clinical trial has found early evidence that a metabolic therapy could improve outcomes for people with ataxia-telangiectasia (A-T),...
      Read more

      Rapid repetitive syllable sounds associate with episodic memory, executive function, and working memory in cognitively healthy and subjectively impaired older adults

      • Posted on 21 July, 2025
        Could a 10-second speech test repeating “pa,” “ta,” “ka” be the key to earlier detection of Alzheimer’s risk? Our new...
        Read more